Figure E2: Proposed algorithm for serological diagnosis of IgE
mediated cannabis sativa allergy. Performance of component resolved
diagnosis based on availability.
REFERENCES
1. Tessmer A, Berlin N, Sussman G, et al. Hypersensitivity reactions to
marijuana. Ann Allergy Asthma Immunol 2012;108(4):282-4. doi:
10.1016/j.anai.2012.01.008 [published Online First: 2012/04/04]
2. Nayak AP, Green BJ, Sussman G, et al. Characterization of Cannabis
sativa allergens. Ann Allergy Asthma Immunol 2013;111(1):32-7.
doi: 10.1016/j.anai.2013.04.018 [published Online First: 2013/06/29]
3. Decuyper, II, Van Gasse AL, Faber MA, et al. Exploring the Diagnosis
and Profile of Cannabis Allergy. J Allergy Clin Immunol Pract2019;7(3):983-89 e5. doi: 10.1016/j.jaip.2018.09.017 [published Online
First: 2018/10/03]
4. Ebo DG, Decuyper, II, Rihs HP, et al. IgE-binding and mast cell
activating capacity of the homologue of the major birch pollen allergen
and profilin from Cannabis sativa. J Allergy Clin Immunol Pract2021 doi: 10.1016/j.jaip.2021.02.012 [published Online First:
2021/02/20]
Ine I. Decuyper, MD, PhD1,2, Hans-Peter Rihs,
PhD3, Christel H. Mertens, MLT1,
Athina Ludovica Van Gasse, MD, PhD1,2, J. Elst,
MSc1, Margaretha A. Faber, MD, PhD1,
Margo M. Hagendorens, MD, PhD1,2, Vito Sabato, MD,
PhD1,4, and Didier G. Ebo, MD,
PhD1,4